Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients

NCT01963663 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Metformin
DRUG: Pioglitazone

Sponsor

Tehran University of Medical Sciences